Ectopic adrenocorticotropic hormone syndrome

doi:10.16138/j.1673-6087.2023.04.006

Abstract

CLC Number:

R586

ZHANG Cui, WANG Weiqing. Ectopic adrenocorticotropic hormone syndrome[J]. Journal of Internal Medicine Concepts & Practice, 2023, 18(04): 242-246.

References 19

[1]	Shepherd FA, Laskey J, Evans WK, et al. Cushing’s syndrome associated with ectopic corticotropin production and small-cell lung cancer[J]. J Clin Oncol, 1992, 10(1): 21-27. pmid: 1309381
[2]	Winquist EW, Laskey J, Crump M, et al. Ketoconazole in the management of paraneoplastic Cushing’s syndrome secondary to ectopic adrenocorticotropin production[J]. J Clin Oncol, 1995, 13(1): 157-164. pmid: 7799015
[3]	Zhang C, Jin J, Xie J, et al. The clinical features and molecular mechanisms of ACTH-secreting pancreatic neuroendocrine tumors[J]. J Clin Endocrinol Metab, 2020, 105(11): dgaa507.
[4]	Isidori AM, Kaltsas GA, Pozza C, et al. The ectopic adrenocorticotropin syndrome: clinical features, diagnosis, management, and long-term follow-up[J]. J Clin Endocrinol Metab, 2006, 91(2): 371-377. doi: 10.1210/jc.2005-1542 URL
[5]	Ilias I, Torpy DJ, Pacak K, et al. Cushing’s syndrome due to ectopic corticotropin secretion: twenty years’ experience at the National Institutes of Health[J]. J Clin Endocrinol Metab, 2005, 90(8): 4955-4962. doi: 10.1210/jc.2004-2527 URL
[6]	Beuschlein F, Hammer GD. Ectopic pro-opiomelanocortin syndrome[J]. Endocrinol Metab Clin North Am, 2002, 31(1): 191-234. doi: 10.1016/S0889-8529(01)00025-1 URL
[7]	Newell-Price J, Bertagna X, Grossman AB, et al. Cushing’s syndrome[J]. Lancet, 2006, 367(9522): 1605-1617. doi: 10.1016/S0140-6736(06)68699-6 pmid: 16698415
[8]	Wang WQ, Ye L, Bi YF, et al. Six cases of ectopic ACTH syndrome caused by thymic carcinoid[J]. J Endocrinol Invest, 2006, 29(4): 293-297. doi: 10.1007/BF03344098 pmid: 16699293
[9]	Ye L, Li X, Kong X, et al. Hypomethylation in the promoter region of POMC gene correlates with ectopic overexpression in thymic carcinoids[J]. J Endocrinol, 2005, 185(2): 337-343. pmid: 15845926
[10]	Li Y, Peng Y, Jiang X, et al. Whole exome sequencing of thymic neuroendocrine tumor with ectopic ACTH syndrome[J]. Eur J Endocrinol, 2017, 176(2): 187-194. pmid: 27913610
[11]	Liu RX, Wang WQ, Ye L, et al. p21-activated kinase 3 is overexpressed in thymic neuroendocrine tumors (carcinoids) with ectopic ACTH syndrome and participates in cell migration[J]. Endocrine, 2010, 38(1): 38-47. doi: 10.1007/s12020-010-9324-6 URL
[12]	Bi YF, Liu RX, Ye L, et al. Gene expression profiles of thymic neuroendocrine tumors (carcinoids) with ectopic ACTH syndrome reveal novel molecular mechanism[J]. Endocr Relat Cancer, 2009, 16(4): 1273-1282. doi: 10.1677/ERC-08-0325 URL
[13]	Bi YF, Ye L, Chen YH, et al. Characteristics of ectopic adrenocorticotropic hormone syndrome due to thymic carcinoid and analysis of the molecular mechanism[J]. Chin Med J (Engl), 2008, 121(7): 667-670.
[14]	Gewirtz G, Yalow RS. Ectopic ACTH production in carcinoma of the lung[J]. J Clin Invest, 1974, 53(4): 1022-1032. pmid: 4360854
[15]	Jiang J, Li N, Wang X, et al. Aberrant expression and modification of silencing mediator of retinoic acid and thyroid hormone receptors involved in the pathogenesis of tumoral cortisol resistance[J]. Endocrinology, 2010, 151(8): 3697-3705. doi: 10.1210/en.2010-0335 pmid: 20555024
[16]	Nieman LK. Molecular derangements and the diagnosis of ACTH-dependent Cushing’s syndrome[J]. Endocr Rev, 2022, 43(5): 852-877. doi: 10.1210/endrev/bnab046 URL
[17]	Reincke M, Ritzel K, Oßwald A, et al. A critical reappraisal of bilateral adrenalectomy for ACTH-dependent Cushing’s syndrome[J]. Eur J Endocrinol, 2015, 173(4): M23-M32. doi: 10.1530/EJE-15-0265 URL
[18]	Young J, Haissaguerre M, Viera-Pinto O, et al. Management of endocrine disease: Cushing’s syndrome due to ectopic ACTH secretion[J]. Eur J Endocrinol, 2020, 182(4): R29-R58. doi: 10.1530/EJE-19-0877 URL
[19]	Guerrero-Pérez F, Peiró I, Marengo AP, et al. Ectopic Cushing’s syndrome due to thymic neuroendocrine tumours: a systematic review[J]. Rev Endocr Metab Disord, 2021, 22(4): 1041-1056. doi: 10.1007/s11154-021-09660-2

Ectopic adrenocorticotropic hormone syndrome

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References 19

Related Articles 9

Recommended Articles

Metrics

Comments

[1]	ZHOU Weiwei, ZHENG Sichang, WANG Weiqing. New understanding of mechanism of Cushing’s disease [J]. Journal of Internal Medicine Concepts & Practice, 2023, 18(04): 247-250.
[2]	JIANG Yiran, WANG Weiqing. Research progress on molecular mechanism of primary aldosteronism [J]. Journal of Internal Medicine Concepts & Practice, 2023, 18(04): 261-265.
[3]	KE Yuya, GONG Yanchun. Research progress of cardiovascular damage in primary aldosteronism [J]. Journal of Internal Medicine Concepts & Practice, 2023, 18(04): 301-304.
[4]	GU Yanyun, ZHOU Weiwei, WANG Weiqing, et al. Primary pigmented nodular adrenocortical disease [J]. Journal of Internal Medicine Concepts & Practice, 2023, 18(04): 230-233.
[5]	WU Luming, WANG Weiqing. Clinical and basic research on adrenal cortical carcinoma [J]. Journal of Internal Medicine Concepts & Practice, 2023, 18(04): 234-238.
[6]	ZHOU Weiwei, WANG Weiqing. Evolution of understanding of primary bilateral macronodular adrenal hyperplasia [J]. Journal of Internal Medicine Concepts & Practice, 2023, 18(04): 239-241.
[7]	LAI Liqin, GONG Yanchun. Research progress of chronic kidney injury in primary aldosteronism [J]. Journal of Internal Medicine Concepts & Practice, 2023, 18(03): 211-214.
[8]	Chinese Society of Endocrinology. Guidelines for clinical management of adrenal disease novel coronavirus infection [J]. Journal of Internal Medicine Concepts & Practice, 2023, 18(01): 16-17.
[9]	. [J]. Journal of Internal Medicine Concepts & Practice, 2021, 16(03): 205-207.